Starling Oncology Inc. (STLN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Starling Oncology Inc., updated every trading day.
Health Care · Medical/Nursing Services
Price
$6.64
+0.76% today
Market cap
$672M
Overall quality
—
Kronos AI 30-day
−11.8%
0 of 8 simulated paths end higher
Starling Oncology Inc. (STLN) is a Health Care company in Medical/Nursing Services, worth $672M. It trades at $6.64, up 0.76% today. 2 analysts' average target of $10.00 implies +50.6% from today's price. Kronos AI's 30-day forecast is −11.8% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $9.00 – $11.00 |
| Analysts | 2 |
| Upside to average | +50.6% |
Kronos AI 30-day forecast
| Expected close | $5.81 (−11.8%) |
| Likely range | −26.4% … −3.6% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medical/Nursing Services
For information only, not investment advice. Prices updated: 2026-10-29.